Lv4
430 积分 2024-05-20 加入
Pretomanid vs delamanid in a bedaquiline-linezolid regimen: efficacy in a high-burden tuberculosis mouse model
7天前
已完结
Adverse events in bedaquiline‐ and pretomanid‐based regimens for drug‐resistant tuberculosis from trial, implementation and pharmacovigilance studies
7天前
已完结
Update on Tuberculosis Treatment and Drug Regimens
7天前
已完结
结核病化学治疗研究年度进展2025
7天前
已完结
Suboptimal moxifloxacin and levofloxacin drug exposure during treatment of patients with multidrug-resistant tuberculosis: results from a prospective study in China
1个月前
已完结
Drug exposure and susceptibility of second-line drugs correlate with treatment response in patients with multidrug-resistant tuberculosis: a multicentre prospective cohort study in China
1个月前
已完结
[Chinese expert consensus on multidrug-resistant tuberculosis and Rifampicin-resistant tuberculosis treatment]
1个月前
已完结
Delamanid when other anti-tuberculosis-treatment regimens failed due to resistance or tolerability
1个月前
已完结
Efficacy and safety of delamanid in combination with an optimised background regimen for treatment of multidrug-resistant tuberculosis: a multicentre, randomised, double-blind, placebo-controlled, parallel group phase 3 trial
1个月前
已完结
皖公网安备34019202002308
